Novartis, CH0012005267

Novartis stock holds steady before the bell after September 21 close

Published on 09/22/2026 at 06:59 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 21, 2026, Novartis stock traded near CHF 116.14 on SIX, while the session opened at CHF 116.42. The shares remained within their recent 52-week range.

Pop-Art-Illustration einer DNA-Doppelhelix mit Kapsel in leuchtendem Halftone-Raster
Novartis AG CH0012005267 – Pop-Art-Comic mit stilisierter DNA-Helix und Kapsel im bunten Halftone-Raster, Illustration mit AI erstellt.

Novartis stock closed at CHF 116.14 on SIX on September 21, 2026, after opening at CHF 116.42. The shares traded near recent levels during the session, with the close positioned between the 52-week low and high.

September 21, 2026 in numbers

Novartis AG (ISIN CH0012005267) remained close to its recent trading range on September 21, 2026. The session opened at CHF 116.42, while the reported close was CHF 116.14 on the Swiss exchange.

Recent company developments included clinical-trial setbacks and a regulatory update concerning Cosentyx. Zacks reported on September 21, 2026, that Novartis received a positive CHMP opinion for another Cosentyx indication.

September 22, 2026 outlook

The company-specific pipeline and regulatory news remain the dated items relevant to Novartis shares as the next SIX session approaches. Yahoo Finance reported on September 22, 2026, on another Novartis pipeline setback.

Disclaimer...

en | CH0012005267 | NOVARTIS | boerse | 70150778 | bgmi